Bactiguard’s Annual Report 2020

Report this content

The annual report for Bactiguard Holding AB (publ) 2020 is now available at www.bactiguard.com.

The annual report is available as a downloadable PDF document in both Swedish and English. A printed version of the report will be available from April 28 and can be ordered by sending an email to: info@bactiguard.com.

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 20.45 CET on March 30, 2021.

For further information, please contact:
Gabriella Caracciolo, CFO and deputy CEO, mobile +46 72 141 62 49
 

About Bactiguard
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.

The Bactiguard technology is based on a thin noble metal alloy coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Urinary catheters with Bactiguard's coating are market leaders in the USA and Japan through our licensing partner BD.

Bactiguard's product portfolio also includes Hydrocyn® aqua, a non-alcoholic product line for wound care and disinfection. Hydrocyn effectively kills viruses, bacteria and fungi while being biocompatible, pH neutral and tissue friendly. The active ingredient hypochlorous acid is the same substance as the body's immune cells use in their defence against infectious organisms.

Bactiguard is in a strong expansion phase in the markets in Europe, China, India and the Middle East through our own product portfolio and by establishing licensing deals in new therapy areas.

Bactiguard has about 180 employees around the world. Its headquarters and one of three production facilities are located in Stockholm, the other two in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
 
Read more about Bactiguard www.bactiguard.com

Tags: